190 related articles for article (PubMed ID: 11069309)
21. Helicobacter pylori eradication increases nocturnal acid breakthrough.
van Herwaarden MA; Samsom M; Smout AJ
Aliment Pharmacol Ther; 2000 Jul; 14(7):961-2. PubMed ID: 10886054
[No Abstract] [Full Text] [Related]
22. [Effect of birid triple viable on peptic ulcer patients with Helicobacter pylori infection].
Xu C; Xiao L; Zou H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 35(9):1000-4. PubMed ID: 20871168
[TBL] [Abstract][Full Text] [Related]
23. [Helicobacter pylori eradication. Therapeutic evolution, value of complementary studies].
Bigard MA
Presse Med; 2001 Sep; 30(26):1305-12. PubMed ID: 11603094
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Helicobacter pylori eradication therapy in chronic liver disease.
Jung SW; Lee SW; Hyun JJ; Kim DI; Koo JS; Yim HJ; Park JJ; Lee HS; Chun HJ; Um SH; Choi JH; Kim CD; Ryu HS
Dig Liver Dis; 2009 Feb; 41(2):134-40. PubMed ID: 18436489
[TBL] [Abstract][Full Text] [Related]
25. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.
Robinson M
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():1-10. PubMed ID: 15496213
[TBL] [Abstract][Full Text] [Related]
26. Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori.
Yazbek PB; Trindade AB; Chin CM; Dos Santos JL
Dig Dis Sci; 2015 Oct; 60(10):2901-12. PubMed ID: 25999247
[TBL] [Abstract][Full Text] [Related]
27. The role of Helicobacter pylori urease in the pathogenesis of gastritis and peptic ulceration.
Mobley HL
Aliment Pharmacol Ther; 1996 Apr; 10 Suppl 1():57-64. PubMed ID: 8730260
[TBL] [Abstract][Full Text] [Related]
28. Effect of Helicobacter pylori infection on gastric juice pH.
Furuta T; Baba S; Takashima M; Futami H; Arai H; Kajimura M; Hanai H; Kaneko E
Scand J Gastroenterol; 1998 Apr; 33(4):357-63. PubMed ID: 9605256
[TBL] [Abstract][Full Text] [Related]
29. 4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study.
Lüth S; Teyssen S; Kölbel CB; Singer MV
Z Gastroenterol; 2001 Apr; 39(4):279-81, 284-5. PubMed ID: 11367976
[TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori, peptic ulcer disease and inhibition of gastric acid secretion.
Rune S
Digestion; 1992; 51 Suppl 1():11-6. PubMed ID: 1397740
[TBL] [Abstract][Full Text] [Related]
31. The rationale of acid suppression in the treatment of acid-related disease.
Mohamed AH; Hunt RH
Aliment Pharmacol Ther; 1994; 8 Suppl 1():3-10. PubMed ID: 7910047
[TBL] [Abstract][Full Text] [Related]
32. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence.
Tytgat GN
Aliment Pharmacol Ther; 1994 Aug; 8(4):359-68. PubMed ID: 7986961
[TBL] [Abstract][Full Text] [Related]
33. Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer.
Kuipers EJ
Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():71-88. PubMed ID: 9146793
[TBL] [Abstract][Full Text] [Related]
34. Clinical efficacy of lansoprazole in eradication of Helicobacter pylori.
Katoh M; Asaka M; Kudoh M; Kagaya H; Katagiri M; Takeda H
J Clin Gastroenterol; 1995; 20 Suppl 2():S112-4. PubMed ID: 7594324
[TBL] [Abstract][Full Text] [Related]
35. High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week.
Xiao SD; Liu WZ; Hu PJ; Xia DH; Tytgat GN
Aliment Pharmacol Ther; 1999 Mar; 13(3):311-5. PubMed ID: 10102963
[TBL] [Abstract][Full Text] [Related]
36. [The several problems and cautions in treatment of Helicobacter pylori infection].
Fukuda Y; Sakagami T
Gan To Kagaku Ryoho; 2004 Oct; 31(10):1465-74. PubMed ID: 15508434
[TBL] [Abstract][Full Text] [Related]
37. Acid acclimation by Helicobacter pylori.
Sachs G; Weeks DL; Wen Y; Marcus EA; Scott DR; Melchers K
Physiology (Bethesda); 2005 Dec; 20():429-38. PubMed ID: 16287992
[TBL] [Abstract][Full Text] [Related]
38. Eradication of Helicobacter pylori does not decrease the long-term use of acid-suppressive medication.
Tan AC; Hartog GD; Mulder CJ
Aliment Pharmacol Ther; 1999 Nov; 13(11):1519-22. PubMed ID: 10571610
[TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.
Thomson AB; Keelan M; Lastiwka R; Appelman-Eszczuk S; Zuk L; Drozdowski L; Prentice A; Sinclair P
Dig Dis Sci; 2003 Oct; 48(10):2045-56. PubMed ID: 14627354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
